Skip to content

Clinical trial of Jing Feng endoscopic system in urology

Clinical trial of Jing Feng endoscopic system in urology

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085547
Enrollment
Unknown
Registered
2024-06-12
Start date
2023-08-25
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

: Stenosis of ureter : renal cancer : renal pelvic carcinoma : Prostatic carcinoma : adrenal adenoma

Interventions

Experimental group:Jingfeng endoscopic abdominal surgery system

Sponsors

Beijing Miyun District Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 78 Years

Inclusion criteria

Inclusion criteria: (Pyeloplasty) Pyeloplasty is required for UPJO patients; Age 18-75 years old, gender unlimited; Agree to sign informed consent forms and be able to follow medical advice and regular follow-up visits. (Patch ureter repair) Patch repair is required to treat patients with ureteral stenosis; Age 18-75 years old, gender unlimited; Agree to sign informed consent forms and be able to follow medical advice and regular follow-up visits. (Ileal ureteral replacement) Ileal ureteral replacement is required to treat patients with long segment ureteral stenosis; Age 18-75 years old, gender unlimited; Agree to sign informed consent forms and be able to follow medical advice and regular follow-up visits. (Vesicoureteral replantation) Patients requiring vesicoureteral replantation for lower segment ureteral stenosis; Age 18-75 years old, gender unlimited; Agree to sign informed consent forms and be able to follow medical advice and regular follow-up visits. (Partial nephrectomy) Eligible patients requiring partial nephrectomy; Age 18-75 years old, gender unlimited; Agree to sign informed consent forms and be able to follow medical advice and regular follow-up visits. (Radical nephrectomy) Eligible patients requiring radical nephrectomy for renal cancer; Age 18-75 years old, gender unlimited; Agree to sign informed consent forms and be able to follow medical advice and regular follow-up visits. (Total nephreteral resection) · Total nephreteral resection is required for upper urothelial carcinoma; · Age 18-75 years old, gender unlimited; (Radical resection of prostate cancer) Patients with prostate cancer who need to have their prostate removed; Aged 18-78, male; (Excision of adrenal tumor) Patients requiring adrenal tumor resection for adrenal functional cortical adenoma; Adenoma less than 4cm Age 18-75 years old, gender unlimited.

Exclusion criteria

Exclusion criteria: Does not meet the inclusion criteria; Have a serious uncontrolled disease or an acute infection; Patients with cardiovascular and cerebrovascular diseases, blood system diseases and diabetes, and their control conditions cannot meet surgical standards; Patients with immune system diseases whose control conditions cannot meet surgical standards; Patients with a history of abdominal and pelvic surgery and severe abdominal and pelvic adhesions;

Design outcomes

Primary

MeasureTime frame
Operation success rate;

Secondary

MeasureTime frame
Surgical margin;Postoperative urinary incontinence;Postoperative urinary tract obstruction;Warm ischemic time;intraoperative blood loss;Prostate specific antigen;

Countries

China

Contacts

Public ContactYaming Gu

Beijing Miyun District Hospital

gymmiyun@126.com+86 136 6134 2987

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026